Abstract
BackgroundRET/PTC (rearranged in transformation/papillary thyroid carcinomas) gene rearrangements are the most frequent genetic alterations identified in papillary thyroid carcinoma. Although it has been established that RET/PTC kinase plays a crucial role in intracellular signaling pathways that regulate cellular transformation, growth, and proliferation in thyroid epithelial cells, the upstream signaling that leads to the activation of RET/PTC is largely unknown. Based on the observation of high levels of PLD expression in human papillary thyroid cancer tissues, we investigated whether PLD plays a role in the regulating the RET/PTC-induced STAT3 activation.MethodsCancer tissue samples were obtained from papillary thyroid cancer patients (n = 6). The expression level of PLD was examined using immunohistochemistry and western blotting. Direct interaction between RET/PTC and PLD was analyzed by co-immunoprecipitation assay. PLD activity was assessed by measuring the formation of [3H]phosphatidylbutanol, the product of PLD-mediated transphosphatidylation, in the presence of n-butanol. The transcriptional activity of STAT3 was assessed by m67 luciferase reporter assay.ResultsIn human papillary thyroid cancer, the expression levels of PLD2 protein were higher than those in the corresponding paired normal tissues. PLD and RET/PTC could be co-immunoprecipitated from cells where each protein was over-expressed. In addition, the activation of PLD by pervanadate triggered phosphorylation of tyrosine 705 residue on STAT-3, and its phosphorylation was dramatically higher in TPC-1 cells (from papillary carcinoma) that have an endogenous RET/PTC1 than in ARO cells (from anaplastic carcinoma) without alteration of total STAT-3 expression. Moreover, the RET/PTC-mediated transcriptional activation of STAT-3 was synergistically increased by over-expression of PLD, whereas the PLD activity as a lipid hydrolyzing enzyme was not affected by RET/PTC.ConclusionThese findings led us to suggest that the PLD synergistically functions to activate the STAT3 signaling by interacting directly with the thyroid oncogenic kinase RET/PTC.
Highlights
rearranged in transformation/papillary thyroid carcinomas (RET/Papillary thyroid carcinoma (PTC)) gene rearrangements are the most frequent genetic alterations identified in papillary thyroid carcinoma
The rearranged in transformation/papillary thyroid carcinomas (RET/PTC)-mediated transcriptional activation of signal transducer and activator of transcription (STAT)-3 was synergistically increased by over-expression of Phospholipase D (PLD), whereas the PLD activity as a lipid hydrolyzing enzyme was not affected by RET/PTC
These findings led us to suggest that the PLD synergistically functions to activate the STAT3 signaling by interacting directly with the thyroid oncogenic kinase RET/PTC
Summary
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) gene rearrangements are the most frequent genetic alterations identified in papillary thyroid carcinoma. It has been established that RET/PTC kinase plays a crucial role in intracellular signaling pathways that regulate cellular transformation, growth, and proliferation in thyroid epithelial cells, the upstream signaling that leads to the activation of RET/PTC is largely unknown. Papillary thyroid carcinoma (PTC) is frequently associated with RET (rearranged in transformation) gene rearrangement that results in fusing the RET tyrosine kinase domain to the N-terminal region of heterologous genes [1]. RET rearrangements are restricted to the thyroid gland, where they are considered specific for papillary carcinoma [2,3]. The rearrangements result in ligand-independent activation of RET tyrosine kinase which is considered crucial for activating the cellular signaling pathways involved in transformation of thyroid cells. RET/PTC transforms thyroid follicular cells in vitro [6], and the specific overexpression of RET/PTC1 or RET/PTC3 in the thyroid of transgenic mice leads to the development of tumors that resemble PTC [7,8,9]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have